Mode
Text Size
Log in / Sign up
N/A Completed N=120 Randomized Treatment

Remote Delivery of Weight Management for Adults With IDD

Source: ClinicalTrials.gov NCT03291509 ↗
Enrolled (actual)
120
Serious AEs
1.7%
Results posted
Mar 2023
Primary outcomePrimary: Change in Weight (kg) — -2.1; -4.9 kg

Summary

The purpose of this study is to compare different weight loss programs in people with IDD to see which program works better.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Weight (kg)
-2.3; -4.5
SECONDARY
Change in Weight (kg)
-2.3; -4.5

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of mild to moderate IDD as determined by a Community Service Provider operating in Kansas under the auspices of a Community Developmental Disability Organization (CDDO). Participants will be judged competent to provide informed consent by their CDDO, or will have a guardian with power of attorney.
  • Ability to provide assent, regardless of guardian consent.
  • BMI of 25 to 45 kg/m2
  • Sufficient functional ability to understand directions, communicate preferences (e.g. foods), wants (e.g. more to eat/drink), and needs (e.g. assistance with food preparation) through spoken language
  • Living at home with a parent/guardian, or in a supported living environment with a caregiver who assists with food shopping, meal planning, and meal preparation and agrees to serve as a study partner
  • No plans to relocate outside the study area over the next 24 months
  • Internet access in the home

Exclusion Criteria

  • Unable to participate in moderate-to-vigorous physical activity (MVPA)
  • Insulin dependent diabetes
  • Participation in a weight management program involving diet and physical activity in the past 6 months
  • Serious food allergies, consuming special diets (vegetarian, Atkins etc.), aversion to common foods (e.g., unwilling to consume dairy products, vegetables), diagnosis of Prader-Willi Syndrome
  • Pregnancy during the previous 6 months, currently lactating or planned pregnancy in the following 24 months.
  • Serious medical risk, e.g., cancer, recent heart attack, stroke, angioplasty
  • Unwilling to be randomized.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03291509). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search